
|Articles|November 1, 2019
- Applied Clinical Trials-11-01-2019
- Volume 28
- Issue 11
Applied Clinical Trials, November 2019 Issue (PDF)
Click the title above to open the Applied Clinical Trials November 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
2020: The Industry’s Future Awaitsover 6 years ago
Establishing Early Phase Capabilities in Malaysiaover 6 years ago
How ICH E6 (R2) Offers Wins with Risk-Based Study Executionover 6 years ago
News Notesover 6 years ago
The Challenges in Fulfilling the Promise of Precision Oncologyover 6 years ago
The ‘Quest’ For an Effective Partner in Pharma And Biotechover 6 years ago
China: A New Era of Drug Development and InnovationNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
2
New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN
3
Global by Design: What 2026 Means for Sites, Sponsors, and Trial Operations
4
ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI
5




